Skip to main content
Top
Published in: Surgical Endoscopy 11/2023

Open Access 18-09-2023 | Metastasis

Robot-assisted fluorescent sentinel lymph node identification in early-stage colon cancer

Authors: Daan J. Sikkenk, Andrea J. Sterkenburg, Thijs A. Burghgraef, Halil Akol, Matthijs P. Schwartz, René Arensman, Paul M. Verheijen, Wouter B. Nagengast, Esther C. J. Consten

Published in: Surgical Endoscopy | Issue 11/2023

Login to get access

Abstract

Background

Patients with cT1-2 colon cancer (CC) have a 10–20% risk of lymph node metastases. Sentinel lymph node identification (SLNi) could improve staging and reduce morbidity in future organ-preserving CC surgery. This pilot study aimed to assess safety and feasibility of robot-assisted fluorescence-guided SLNi using submucosally injected indocyanine green (ICG) in patients with cT1-2N0M0 CC.

Methods

Ten consecutive patients with cT1-2N0M0 CC were included in this prospective feasibility study. Intraoperative submucosal, peritumoral injection of ICG was performed during a colonoscopy. Subsequently, the near-infrared fluorescence ‘Firefly’ mode of the da Vinci Xi robotic surgical system was used for SLNi. SLNs were marked with a suture, after which a segmental colectomy was performed. The SLN was postoperatively ultrastaged using serial slicing and immunohistochemistry, in addition to the standard pathological examination of the specimen. Colonoscopy time, detection time (time from ICG injection to first SLNi), and total SLNi time were measured (time from the start of colonoscopy to start of segmental resection). Intraoperative, postoperative, and pathological outcomes were registered.

Results

In all patients, at least one SLN was identified (mean 2.3 SLNs, SLN diameter range 1–13 mm). No tracer-related adverse events were noted. Median colonoscopy time was 12 min, detection time was 6 min, and total SLNi time was 30.5 min. Two patients had lymph node metastases present in the SLN, and there were no patients with false negative SLNs. No patient was upstaged due to ultrastaging of the SLN after an initial negative standard pathological examination. Half of the patients unexpectedly had pT3 tumours.

Conclusions

Robot-assisted fluorescence-guided SLNi using submucosally injected ICG in ten patients with cT1-2N0M0 CC was safe and feasible. SLNi was performed in an acceptable timespan and SLNs down to 1 mm were detected. All lymph node metastases would have been detected if SLN biopsy had been performed.
Literature
3.
go back to reference Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Nagtegaal ID, Krul MF, Kok NFM, Kuhlmann KFD, Vink GR, van Leerdam ME, Elferink MAG (2022) Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Lancet Gastroenterol Hepatol 7:60–68. https://doi.org/10.1016/S2468-1253(21)00368-XCrossRefPubMed Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Nagtegaal ID, Krul MF, Kok NFM, Kuhlmann KFD, Vink GR, van Leerdam ME, Elferink MAG (2022) Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Lancet Gastroenterol Hepatol 7:60–68. https://​doi.​org/​10.​1016/​S2468-1253(21)00368-XCrossRefPubMed
4.
go back to reference Backes Y, Elias SG, Bhoelan BS, Groen JN, van Bergeijk J, Seerden TCJ, Pullens HJM, Spanier BWM, Geesing JMJ, Kessels K, Kerkhof M, Siersema PD, de Vos tot Nederveen Cappel WH, van Lelyveld N, Wolfhagen FHJ, ter Borg F, Offerhaus GJA, Lacle MM, Moons LMG (2017) The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study. BMC Med 15:1–11. https://doi.org/10.1186/s12916-017-0892-7CrossRef Backes Y, Elias SG, Bhoelan BS, Groen JN, van Bergeijk J, Seerden TCJ, Pullens HJM, Spanier BWM, Geesing JMJ, Kessels K, Kerkhof M, Siersema PD, de Vos tot Nederveen Cappel WH, van Lelyveld N, Wolfhagen FHJ, ter Borg F, Offerhaus GJA, Lacle MM, Moons LMG (2017) The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study. BMC Med 15:1–11. https://​doi.​org/​10.​1186/​s12916-017-0892-7CrossRef
10.
go back to reference Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, Johnson CD, Pilkington SA, Arraras J, Ben-Josef E, Pullyblank AM, Fayers P, Blazeby JM (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45:3017–3026. https://doi.org/10.1016/j.ejca.2009.08.014CrossRef Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, Johnson CD, Pilkington SA, Arraras J, Ben-Josef E, Pullyblank AM, Fayers P, Blazeby JM (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45:3017–3026. https://​doi.​org/​10.​1016/​j.​ejca.​2009.​08.​014CrossRef
11.
go back to reference Weixler B, Warschkow R, Güller U, Zettl A, von Holzen U, Schmied B, Zuber M (2016) Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival. BMC Cancer 16(1):1–7CrossRef Weixler B, Warschkow R, Güller U, Zettl A, von Holzen U, Schmied B, Zuber M (2016) Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival. BMC Cancer 16(1):1–7CrossRef
12.
go back to reference Saha S, Elgamal M, Cherry M, Buttar R, Pentapati S, Mukkamala S, Devisetty K, Kaushal S, Alnounou M, Singh T, Grewal S, Eilender D, Arora M, Wiese D (2018) Challenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapy. Clin Exp Metastasis 35:463–469CrossRefPubMed Saha S, Elgamal M, Cherry M, Buttar R, Pentapati S, Mukkamala S, Devisetty K, Kaushal S, Alnounou M, Singh T, Grewal S, Eilender D, Arora M, Wiese D (2018) Challenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapy. Clin Exp Metastasis 35:463–469CrossRefPubMed
14.
go back to reference Bilchik AJ, Trocha SD (2003) Lymphatic mapping and sentinel node analysis to optimize laparoscopic resection and staging of colorectal cancer: an update. Cancer Control 10(3):219–223CrossRefPubMed Bilchik AJ, Trocha SD (2003) Lymphatic mapping and sentinel node analysis to optimize laparoscopic resection and staging of colorectal cancer: an update. Cancer Control 10(3):219–223CrossRefPubMed
15.
go back to reference Leicher LW, Huisman JF, van Grevenstein WMU, Didden P, Backes Y, Offerhaus GJA, Laclé MM, Moll FCP, Geesing JMJ, Smakman N, Droste JSTS, Verdaasdonk EGG, Ter Borg F, Talsma AK, Erkelens GW, van der Zaag ES, Schrauwen RWM, van Wely BJ, Schot I, Vermaas M, van Bergeijk JD, Sietses C, Hazen WL, Wasowicz DK, Ramsoekh D, Tuynman JB, Alderlieste YA, Renger R-J, Oort FA, Bilgen EJS, Vleggaar FP, de Vos VasenTot Nederveen Cappel HFAWH, Moons LMG, van Westreenen HL (2022) Colonoscopic-assisted laparoscopic wedge resection for colonic lesions: a prospective multicentre cohort study (LIMERIC-study). Ann Surg. https://doi.org/10.1097/SLA.0000000000005417CrossRefPubMed Leicher LW, Huisman JF, van Grevenstein WMU, Didden P, Backes Y, Offerhaus GJA, Laclé MM, Moll FCP, Geesing JMJ, Smakman N, Droste JSTS, Verdaasdonk EGG, Ter Borg F, Talsma AK, Erkelens GW, van der Zaag ES, Schrauwen RWM, van Wely BJ, Schot I, Vermaas M, van Bergeijk JD, Sietses C, Hazen WL, Wasowicz DK, Ramsoekh D, Tuynman JB, Alderlieste YA, Renger R-J, Oort FA, Bilgen EJS, Vleggaar FP, de Vos VasenTot Nederveen Cappel HFAWH, Moons LMG, van Westreenen HL (2022) Colonoscopic-assisted laparoscopic wedge resection for colonic lesions: a prospective multicentre cohort study (LIMERIC-study). Ann Surg. https://​doi.​org/​10.​1097/​SLA.​0000000000005417​CrossRefPubMed
18.
22.
26.
27.
go back to reference Grinnell RS (1966) Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg 163(2):272CrossRefPubMedPubMedCentral Grinnell RS (1966) Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg 163(2):272CrossRefPubMedPubMedCentral
36.
37.
go back to reference Saha S, Johnston G, Korant A, Shaik M, Kanaan M, Johnston R, Ganatra B, Kaushal S, Desai D, Mannam S (2013) Aberrant drainage of sentinel lymph nodes in colon cancer and its impact on staging and extent of operation. Am J Surg 205:302–305CrossRefPubMed Saha S, Johnston G, Korant A, Shaik M, Kanaan M, Johnston R, Ganatra B, Kaushal S, Desai D, Mannam S (2013) Aberrant drainage of sentinel lymph nodes in colon cancer and its impact on staging and extent of operation. Am J Surg 205:302–305CrossRefPubMed
38.
go back to reference Saha S, Philimon B, Efeson M, Helina A, Elgamal M, Kiya G, Hilkiah S, Arora M, Wiese D, Kitagawa Y (2022) The role of sentinel lymph node mapping in colon cancer: detection of micro-metastasis, effect on survival, and driver of a paradigm shift in extent of colon resection. Clin Exp Metastasis 39:109–115. https://doi.org/10.1007/s10585-021-10121-yCrossRefPubMed Saha S, Philimon B, Efeson M, Helina A, Elgamal M, Kiya G, Hilkiah S, Arora M, Wiese D, Kitagawa Y (2022) The role of sentinel lymph node mapping in colon cancer: detection of micro-metastasis, effect on survival, and driver of a paradigm shift in extent of colon resection. Clin Exp Metastasis 39:109–115. https://​doi.​org/​10.​1007/​s10585-021-10121-yCrossRefPubMed
40.
go back to reference van der Pas MHGM, Ankersmit M, Stockmann HBAC, Silvis R, van Grieken NCT, Bril H, Meijerink WJHJ (2013) Laparoscopic sentinel lymph node identification in patients with colon carcinoma using a near-infrared dye: description of a new technique and feasibility study. J Laparoendosc Adv Surg Tech 23:367–371. https://doi.org/10.1089/lap.2012.0407CrossRef van der Pas MHGM, Ankersmit M, Stockmann HBAC, Silvis R, van Grieken NCT, Bril H, Meijerink WJHJ (2013) Laparoscopic sentinel lymph node identification in patients with colon carcinoma using a near-infrared dye: description of a new technique and feasibility study. J Laparoendosc Adv Surg Tech 23:367–371. https://​doi.​org/​10.​1089/​lap.​2012.​0407CrossRef
43.
go back to reference Nagata K, Endo S, Hidaka E, Tanaka JI, Kudo SE, Shiokawa A (2006) Laparoscopic sentinel node mapping for colorectal cancer using infrared ray laparoscopy. Anticancer Res 26:2307–2311PubMed Nagata K, Endo S, Hidaka E, Tanaka JI, Kudo SE, Shiokawa A (2006) Laparoscopic sentinel node mapping for colorectal cancer using infrared ray laparoscopy. Anticancer Res 26:2307–2311PubMed
44.
go back to reference Dan AG, Saha S, Monson KM, Wiese D, Schochet E, Barber KR, Ganatra B, Desai D, Kaushal S (2014) 1% lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors. Arch Surg 139:1180–1184CrossRef Dan AG, Saha S, Monson KM, Wiese D, Schochet E, Barber KR, Ganatra B, Desai D, Kaushal S (2014) 1% lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors. Arch Surg 139:1180–1184CrossRef
53.
go back to reference de Jongh SJ, Tjalma JJJ, Koller M, Linssen MD, Vonk J, Dobosz M, Jorritsma-Smit A, Kleibeuker JH, Hospers GAP, Havenga K, Hemmer PHJ, Karrenbeld A, van Dam GM, van Etten B, Nagengast WB (2020) Back-table fluorescence-guided imaging for circumferential resection margin evaluation using bevacizumab-800CW in patients with locally advanced rectal cancer. J Nucl Med 61:655–661. https://doi.org/10.2967/jnumed.119.232355CrossRefPubMedPubMedCentral de Jongh SJ, Tjalma JJJ, Koller M, Linssen MD, Vonk J, Dobosz M, Jorritsma-Smit A, Kleibeuker JH, Hospers GAP, Havenga K, Hemmer PHJ, Karrenbeld A, van Dam GM, van Etten B, Nagengast WB (2020) Back-table fluorescence-guided imaging for circumferential resection margin evaluation using bevacizumab-800CW in patients with locally advanced rectal cancer. J Nucl Med 61:655–661. https://​doi.​org/​10.​2967/​jnumed.​119.​232355CrossRefPubMedPubMedCentral
54.
go back to reference Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM (2016) Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol 1:283–290. https://doi.org/10.1016/S2468-1253(16)30082-6CrossRefPubMed Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM (2016) Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol 1:283–290. https://​doi.​org/​10.​1016/​S2468-1253(16)30082-6CrossRefPubMed
56.
go back to reference Vonk J, de Wit JG, Voskuil FJ, Tang YH, Hooghiemstra WT, Linssen MD, van den Broek E, Doff JJ, de Visscher SA, Schepman KP, van der Vegt B, van Dam GM, Witjes MJ (2021) Epidermal growth factor receptor targeted fluorescence molecular imaging for postoperative lymph node assessment in patients with oral cancer. J Nucl Med. https://doi.org/10.2967/jnumed.121.262530CrossRefPubMed Vonk J, de Wit JG, Voskuil FJ, Tang YH, Hooghiemstra WT, Linssen MD, van den Broek E, Doff JJ, de Visscher SA, Schepman KP, van der Vegt B, van Dam GM, Witjes MJ (2021) Epidermal growth factor receptor targeted fluorescence molecular imaging for postoperative lymph node assessment in patients with oral cancer. J Nucl Med. https://​doi.​org/​10.​2967/​jnumed.​121.​262530CrossRefPubMed
57.
go back to reference Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL (2018) Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol 3:181–191. https://doi.org/10.1016/S2468-1253(17)30395-3CrossRefPubMed Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL (2018) Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol 3:181–191. https://​doi.​org/​10.​1016/​S2468-1253(17)30395-3CrossRefPubMed
Metadata
Title
Robot-assisted fluorescent sentinel lymph node identification in early-stage colon cancer
Authors
Daan J. Sikkenk
Andrea J. Sterkenburg
Thijs A. Burghgraef
Halil Akol
Matthijs P. Schwartz
René Arensman
Paul M. Verheijen
Wouter B. Nagengast
Esther C. J. Consten
Publication date
18-09-2023
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 11/2023
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-023-10394-2

Other articles of this Issue 11/2023

Surgical Endoscopy 11/2023 Go to the issue